Hanover Health, part of the wider Hanover communications and public affairs consultancy group, has created a new market access-focused practice at its London and Brussels hubs.
Adding to the health specialist’s three existing practices – Health Communications and UK and European Health Policy and Advocacy – Healthcare Market Access will be led by director Jing Wang-Silvanto.
Wang-Silvanto joins the new practice from WG Access, where she was director for value access strategy and head of health economics, and also brings client-side expertise from Bristol-Myers Squibb, GlaxoSmithKline and Novartis.
Her team will offer pricing and managed access, early access and payer engagement, and health technology assessment support for pharma clients across Europe.
Andrew Harrison, Hanover’s managing director of health, said: “Health system finances are squeezed and there is increased need for companies to demonstrate the value of their products and services.
“There are plenty of market access consultancies, but Hanover’s ability to join market access with award-winning policy, advocacy and communications campaigns provides a unique offer that can bring change for clients.
“Market Access is a natural extension of Hanover’s health work. For a while clients have asked the team to support pricing, health economics and early access work.
“Our growth in health in the UK and internationally, and in communications as well as policy, gives us the confidence to invest in expanding our services.”